Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups.

Saved in:
Bibliographic Details
Title: Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups.
Authors: Gisslinger H; Medical University Vienna, Department of Internal Medicine I, Division of Haematology and Blood Coagulation, Vienna, Austria., Klade C; AOP Orphan Pharmaceuticals AG, Vienna, Austria., Georgiev P; University Multiprofile Hospital for Active Treatment 'Sveti Georgi', Clinic of Hematology, Medical University of Plovdiv, Plovdiv, Bulgaria., Krochmalczyk D; University Hospital in Krakow, Teaching Unit of the Hematology Department, Krakow, Poland., Gercheva-Kyuchukova L; Multiprofile Hospital for Active Treatment 'Sveta Marina', Clinical Hematology Clinic, Varna, Bulgaria., Egyed M; Kaposi MorCounty Teaching Hospital, Department of Internal Medicine II, Kaposvar, Hungary., Rossiev V; Samara Kalinin Regional Clinical Hospital, Samara, Russia., Dulicek P; University Hospital Hradec Kralove, Department of Clinical Hematology, Hradec Kralove, Czech Republic., Illes A; University of Debrecen, Faculty of Medicine, Department of Hematology, Debrecen, Hungary., Pylypenko H; Cherkasy Regional Oncology Centre, Regional Treatment and Diagnostics Haematology Centre, Department of Hematology, Cherkasy, Ukraine., Sivcheva L; Multiprofile Hospital for Active Treatment - HristoBotev, First Department of Internal Medicine, Vratsa, Bulgaria., Mayer J; University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology, Brno, Czech Republic., Yablokova V; Yaroslavl Regional Clinical Hospital, Department of Hematology, Yaroslavl, Russia., Krejcy K; AOP Orphan Pharmaceuticals AG, Vienna, Austria., Hasselbalch HC; Department of Hematology, Zealand University Hospital, Roskilde, University of Copenhagen, Denmark., Kralovics R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria and CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Kiladjian JJ; Université de Paris, CIC 1427, Inserm, Paris, France and Centre d'Investigations Cliniques, AP-HP, Hospital Saint-Louis, Paris, France.
Source: HemaSphere [Hemasphere] 2020 Oct 20; Vol. 4 (6), pp. e485. Date of Electronic Publication: 2020 Oct 20 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2572-9241
DOI:10.1097/HS9.0000000000000485